• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

coronavirus

Here at MassDevice — medtech's online business journal — we're covering news about the coronavirus (COVID-19) pandemic daily. Here is the latest about coronavirus and the medical device industry, regulatory changes related to the pandemic, new tests for the virus, vaccine development, and much more.

ProPhase Labs debuts single saliva test for COVID, flu

February 9, 2021 By Sean Whooley

ProPhase Labs (NSDQ:PRPH) announced today that it is introducing a new saliva-based test for COVID-19, Influenza A, B and more. Garden City, N.Y.-based ProPhase Labs said in a news release that it filed for FDA emergency use authorization for its two new testing methodologies, which integrate the Spectrum Solutions saliva self-collection system with a new […]

Filed Under: Diagnostics, Featured, Genomics/Molecular Diagnostics Tagged With: coronavirus, COVID-19, FDA, ProPhase Labs, Spectrum Solutions

South Africa pauses rollout of AstraZeneca COVID-19 vaccine

February 8, 2021 By Brian Buntz

South Africa has scrapped its plans to vaccinate a portion of its population with the COVID-19 vaccine from Oxford University and AstraZeneca (LON:AZN) after a small study showed it was ineffective against a variant widely circulating there. In the interim, South Africa will rely on vaccines from Johnson & Johnson (NYSE:JNJ) and Pfizer (NYSE:PFE). Researchers at Oxford University […]

Filed Under: Pharmaceutical Tagged With: AstraZeneca plc, B.1.351, coronavirus, COVID-19, COVID-19 vaccine, Johnson & Johnson, Oxford University, SARS-CoV-2, South Africa

Hillrom beats The Street in Q1, raises 2021 guidance

February 8, 2021 By Sean Whooley

Hillrom (NYSE:HRC) shares remain up after Street-beating first-quarter results and a raised 2021 guidance. The Chicago-based company posted profits of $58 million, or 88¢ per share, on sales of $741.1 million for the three months ended Dec. 31, 2020, for a 47.7% bottom-line gain on sales growth of 8.2%. Adjusted to exclude one-time items, earnings […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: coronavirus, COVID-19, Hillrom

Feds to order 61M more at-home coronavirus tests, build surgical glove factories

February 5, 2021 By Nancy Crotti

Just days after ordering 8.5 million at-home tests from Ellume, the Biden administration announced today that it’s in talks with six other at-home coronavirus test manufacturers. In an online briefing, Tim Manning, the national supply chain coordinator for COVID response, told reporters that these companies could produce another 61 million at-home tests by the end of […]

Filed Under: Business/Financial News, Contract Manufacturing, Diagnostics, Featured, Hospital Care, Pharmaceutical Tagged With: coronavirus, COVID-19, COVID-19 vaccine, Defense Production Act, Joe Biden, Pfizer

Johnson & Johnson applies for vaccine approval from FDA

February 5, 2021 By Sean Whooley

Johnson & Johnson (NYSE:JNJ) announced that it submitted an FDA emergency use authorization (EUA) application for its COVID-19 vaccine candidate. New Brunswick, N.J.-based J&J’s Janssen Biotech subsidiary submitted the application for its investigational single-dose Janssen COVID-19 vaccine candidate, based on safety and efficacy data from its Phase 3 Ensemble clinical trial that met all of its […]

Filed Under: Clinical Trials, Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: coronavirus, COVID-19, COVID-19 vaccine, COVID-19 vaccine trial, Janssen Biotech, Janssen Pharmaceuticals, Johnson & Johnson

Which companies will likely produce the most COVID-19 vaccine in 2021? 

February 5, 2021 By Brian Buntz

Since the beginning of the pandemic, much of society has pinned its hopes on the availability of a vaccine. Now that several are available across the world, there is hope, said Dr. Anthony Fauci, chief medical advisor to President Joe Biden, in a recent JAMA interview. “There’s light at the end of the tunnel.” One thing that […]

Filed Under: Pharmaceutical Tagged With: coronavirus, COVID-19, Johnson and Johnson, Moderna

Cardinal Health posts Street-beating Q2, raises EPS guidance

February 5, 2021 By Sean Whooley

Cardinal Health (NYSE:CAH) shares dipped slightly on second-quarter results that topped the consensus forecast. The Dublin, Ohio-based company posted profits of $629 million, or $2.13 per share, on sales of $41.5 billion for the three months ended Dec. 31, 2020, for a more-than doubled bottom-line on sales growth of 4.5%. Adjusted to exclude one-time items, earnings […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Cardinal Health, coronavirus, COVID-19, PPE

Align Technology rises on Street-beating, record-breaking Q4 revenues

February 4, 2021 By Sean Whooley

Align Technology (NSDQ:ALGN) shares skyrocketed today on fourth-quarter results that topped the consensus forecast. ALGN shares were up 13.44% at $619.60 per share in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 2.1%. The Tempe, Ariz.-based dental aligner maker posted profits of $133.8 […]

Filed Under: Business/Financial News, Dental, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Align Technology, coronavirus, COVID-19

Pandemic Emergency Manufacturing Act would supplement DPA

February 4, 2021 By Nancy Crotti

A rewritten pandemic manufacturing bill was introduced to both houses of Congress yesterday to enable the federal government to manufacture or contract with existing manufacturers to make products to fight COVID-19. The bill, introduced by Sen. Elizabeth Warren (D-Mass.) and Rep. Jan Schakowsky (D-Ill.), builds off the COVID-19 Emergency Manufacturing Act, introduced in 2020 to […]

Filed Under: Business/Financial News, Contract Manufacturing, Diagnostics, Featured, Pharmaceutical, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Defense Production Act, Donald Trump, Joe Biden, personal protective equipment, vaccines

Quidel opens new COVID-19 antigen test factory in Calif.

February 4, 2021 By Danielle Kirsh

Quidel Corp. (NSDW:QDEL) yesterday said it has opened a manufacturing facility in Carlsbad, Calif. to produce its QuickVue line of COVID-19 rapid antigen tests. The new 128,000 sq. ft facility will become the San Diego-based company’s highest-volume production plant. It will begin operations during the second half of 2021 with a goal of producing 600 million […]

Filed Under: Diagnostics Tagged With: coronavirus, COVID-19, Quidel Corp.

Becton Dickinson beats The Street, raises 2021 guidance

February 4, 2021 By Sean Whooley

Becton Dickinson (NYSE:BDX) shares dipped slightly despite first-quarter results that came in well above the consensus forecast. The Franklin Lakes, N.J.-based company posted profits of $981 million, or $3.35 per share, on sales of $5.3 billion for the three months ended Dec. 31, 2020, tripling its bottom-line on sales growth of 25.8%. Adjusted to exclude one-time […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, MassDevice Earnings Roundup, Wall Street Beat Tagged With: BD, becton dickinson, coronavirus, COVID-19

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Interim pages omitted …
  • Go to page 77
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS